Does levetiracetam (Levo) cause fatigue?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Does Levetiracetam Cause Fatigue?

Yes, levetiracetam (LEV) does cause fatigue, and this is a well-documented adverse effect that occurs significantly more often than with placebo.

Evidence from Clinical Trials

The most robust evidence comes from multiple randomized controlled trials and meta-analyses:

  • Fatigue/asthenia is one of the five most common adverse effects of LEV 1. In pivotal trials for refractory partial epilepsy, asthenia (weakness/fatigue) consistently appeared among the top adverse events alongside somnolence, dizziness, headache, and infection 1.

  • Meta-analytic data confirms significantly increased risk: Patients treated with LEV demonstrate a 48% higher risk of asthenia/fatigue compared to placebo (OR 1.48,95% CI: 1.04-2.11) 2. Another meta-analysis found LEV was significantly associated with asthenia/fatigue (OR 1.71,95% CI: 1.15-2.54) 3.

  • Prevalence in clinical practice: Real-world data shows that 36.6% of patients report fatigue as "always a problem" during AED treatment, and fatigue is specifically more likely with LEV (42.3% vs. 33.2% with other AEDs) 4. This association persists even in monotherapy patients (41.7% vs. 30.3%) 4.

Clinical Characteristics

Key features of LEV-associated fatigue:

  • Not dose-dependent: Unlike some adverse effects, no clear dose-response relationship exists for fatigue 5. This means higher doses don't necessarily cause more fatigue.

  • Gender differences: Females are significantly more likely to report fatigue (64.8% vs. 35.2%) 4.

  • Independent of mood effects: The fatigue is not mediated by depression or negative mood effects 4, meaning it's a direct pharmacological effect rather than secondary to psychiatric symptoms.

  • Generally mild and tolerable: While common, most cases are mild. In pediatric studies, fatigue was among the most common side effects but rarely required discontinuation 6.

Practical Management

When prescribing LEV, counsel patients that:

  • Fatigue occurs in approximately 40% of patients
  • It may be more pronounced in women
  • The effect is not necessarily worse at higher doses
  • It typically does not worsen over time or indicate depression
  • Most patients tolerate it without needing to discontinue

If fatigue becomes problematic, consider dose adjustment or switching to an alternative antiepileptic medication, as the fatigue is a direct LEV-specific effect 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.